108 related articles for article (PubMed ID: 32157522)
1. Roux-en-Y Gastric Bypass for T2D Treatment in Chinese Patients with Low BMI: 5-Year Outcomes.
Wang C; Zhang H; Yu H; Bao Y; Zhang P; Di J
Obes Surg; 2020 Jul; 30(7):2588-2597. PubMed ID: 32157522
[TBL] [Abstract][Full Text] [Related]
2. Effect of Roux-en-Y Gastric Bypass on Remission of T2D: Medium-Term Follow-up in Chinese Patients with Different BMI Obesity Class.
Zhang H; Han X; Yu H; Di J; Zhang P; Jia W
Obes Surg; 2017 Jan; 27(1):134-142. PubMed ID: 27312346
[TBL] [Abstract][Full Text] [Related]
3. Effect of Roux-en-Y gastric bypass on the remission of type 2 diabetes: a 3-year study in Chinese patients with a BMI <30 kg/m
Di J; Zhang H; Yu H; Zhang P; Wang Z; Jia W
Surg Obes Relat Dis; 2016 Aug; 12(7):1357-1363. PubMed ID: 27387699
[TBL] [Abstract][Full Text] [Related]
4. Cost-Utility of Laparoscopic Roux-en-Y Gastric Bypass in Chinese Patients with Type 2 Diabetes and Obesity with a BMI ≥ 27.5 kg/m2: a Multi-Center Study with a 4-Year Follow-Up of Surgical Cohort.
Tu Y; Wang L; Wei L; Xu Y; Han X; Han J; Yu H; Zheng C; Bao Y; Jia W
Obes Surg; 2019 Dec; 29(12):3978-3986. PubMed ID: 31338737
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic gastric bypass for the treatment of type 2 diabetes: a comparison of Roux-en-Y versus single anastomosis gastric bypass.
Almalki OM; Lee WJ; Chong K; Ser KH; Lee YC; Chen SC
Surg Obes Relat Dis; 2018 Apr; 14(4):509-515. PubMed ID: 29555031
[TBL] [Abstract][Full Text] [Related]
6. Two-year outcomes of Roux-en-Y gastric bypass vs medical treatment in type 2 diabetes with a body mass index lower than 32.5 kg/m
Ling J; Tang H; Meng H; Wu L; Zhu L; Zhu S
J Endocrinol Invest; 2022 Sep; 45(9):1729-1740. PubMed ID: 35596918
[TBL] [Abstract][Full Text] [Related]
7. Factors Mediating Type 2 Diabetes Remission and Relapse after Gastric Bypass Surgery.
Pessoa BM; Browning MG; Mazzini GS; Wolfe L; Kaplan A; Khoraki J; Campos GM
J Am Coll Surg; 2020 Jan; 230(1):7-16. PubMed ID: 31672669
[TBL] [Abstract][Full Text] [Related]
8. Changes in bone quality after Roux-en-Y gastric bypass: A prospective cohort study in subjects with and without type 2 diabetes.
Blom-Høgestøl IK; Mala T; Kristinsson JA; Brunborg C; Gulseth HL; Eriksen EF
Bone; 2020 Jan; 130():115069. PubMed ID: 31593823
[TBL] [Abstract][Full Text] [Related]
9. Visceral fat area as a new predictor of short-term diabetes remission after Roux-en-Y gastric bypass surgery in Chinese patients with a body mass index less than 35 kg/m2.
Yu H; Di J; Bao Y; Zhang P; Zhang L; Tu Y; Han X; Jia W
Surg Obes Relat Dis; 2015; 11(1):6-11. PubMed ID: 25547054
[TBL] [Abstract][Full Text] [Related]
10. Type 2 Diabetes Remission in Patients with Heterozygous Variants in the Leptin-Melanocortin Pathway after Roux-en-Y Gastric Bypass: A Matched Case-Control Study.
Anazco D; Ghusn W; Campos A; Cifuentes L; Fansa S; Tama E; Bublitz JT; Gala K; Hurtado MD; Olson JE; Acosta A
Obes Surg; 2023 Nov; 33(11):3502-3509. PubMed ID: 37798511
[TBL] [Abstract][Full Text] [Related]
11. Type 2 diabetes remission after Roux-en-Y gastric bypass: a multicentered experience with long-term follow-up.
Hage K; Ikemiya K; Ghusn W; Lu L; Kennel KA; McKenzie TJ; Kellogg TA; Abu Dayyeh BK; Higa KD; Spaniolas K; Ma P; Ghanem OM
Surg Obes Relat Dis; 2023 Dec; 19(12):1339-1345. PubMed ID: 37914608
[TBL] [Abstract][Full Text] [Related]
12. Bone Health in Patients with Type 2 Diabetes Treated by Roux-En-Y Gastric Bypass and the Role of Diabetes Remission.
Madsen LR; Espersen R; Ornstrup MJ; Jørgensen NR; Langdahl BL; Richelsen B
Obes Surg; 2019 Jun; 29(6):1823-1831. PubMed ID: 30719648
[TBL] [Abstract][Full Text] [Related]
13. Effect of Roux-en-Y Gastric Bypass with Different Lengths of Biliopancreatic and Alimentary Limbs for Patients with Type 2 Diabetes Mellitus and a BMI < 35 kg/m
Gao X; Zhu L; Wang G; Li W; Song Z; Zhu S; Li P
Obes Surg; 2021 Nov; 31(11):4877-4884. PubMed ID: 34403077
[TBL] [Abstract][Full Text] [Related]
14. Roux-en-Y gastric bypass for nonobese patients with uncontrolled type 2 diabetes: a long-term evaluation.
Ferraz ÁAB; de Sá VCT; Santa-Cruz F; Siqueira LT; Silva LB; Campos JM
Surg Obes Relat Dis; 2019 May; 15(5):682-687. PubMed ID: 31005458
[TBL] [Abstract][Full Text] [Related]
15. Should Roux-en-Y gastric bypass biliopancreatic limb length be tailored to achieve improved diabetes outcomes?
Nora M; Morais T; Almeida R; Guimarães M; Monteiro MP
Medicine (Baltimore); 2017 Dec; 96(48):e8859. PubMed ID: 29310367
[TBL] [Abstract][Full Text] [Related]
16. Roux-en-Y gastric bypass surgery improves hepatic glucose metabolism and reduces plasma kisspeptin levels in morbidly obese patients with type 2 diabetes.
Flynn CR; Albaugh VL; Tamboli RA; Gregory JM; Bosompem A; Sidani RM; Winnick JJ
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G370-G374. PubMed ID: 31709832
[TBL] [Abstract][Full Text] [Related]
17. Can low BMI Chinese patients with type 2 diabetes benefit from laparoscopic Roux-en-Y gastric bypass surgery?
Wang G; Zhu L; Li W; Yang X; Li P; Zhu S
Surg Obes Relat Dis; 2016 Dec; 12(10):1890-1895. PubMed ID: 27720195
[TBL] [Abstract][Full Text] [Related]
18. Decreased visceral fat area correlates with improved total testosterone levels after Roux-en-Y gastric bypass in obese Chinese males with type 2 diabetes: a 12-month follow-up.
Liu F; Tu Y; Zhang P; Bao Y; Han J; Jia W
Surg Obes Relat Dis; 2018 Apr; 14(4):462-468. PubMed ID: 29254689
[TBL] [Abstract][Full Text] [Related]
19. Early resolution of type 2 diabetes seen after Roux-en-Y gastric bypass and vertical sleeve gastrectomy.
Bayham BE; Greenway FL; Bellanger DE; O'Neil CE
Diabetes Technol Ther; 2012 Jan; 14(1):30-4. PubMed ID: 21933001
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Four Risk Prediction Models for Diabetes Remission after Roux-en-Y Gastric Bypass Surgery in Obese Chinese Patients with Type 2 Diabetes Mellitus.
Kam H; Tu Y; Pan J; Han J; Zhang P; Bao Y; Yu H
Obes Surg; 2020 Jun; 30(6):2147-2157. PubMed ID: 31898049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
